vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and Navitas Semiconductor Corp (NVTS). Click either name above to swap in a different company.

Navitas Semiconductor Corp is the larger business by last-quarter revenue ($8.6M vs $7.8M, roughly 1.1× CRYO CELL INTERNATIONAL INC). On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -38.7%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -35.2%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.

CCEL vs NVTS — Head-to-Head

Bigger by revenue
NVTS
NVTS
1.1× larger
NVTS
$8.6M
$7.8M
CCEL
Growing faster (revenue YoY)
CCEL
CCEL
+36.4% gap
CCEL
-2.3%
-38.7%
NVTS
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-35.2%
NVTS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CCEL
CCEL
NVTS
NVTS
Revenue
$7.8M
$8.6M
Net Profit
$-3.8M
Gross Margin
77.9%
98.6%
Operating Margin
-50.6%
-260.6%
Net Margin
-48.7%
Revenue YoY
-2.3%
-38.7%
Net Profit YoY
-105.1%
EPS (diluted)
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
NVTS
NVTS
Q1 26
$8.6M
Q4 25
$7.8M
$7.3M
Q3 25
$7.8M
$10.1M
Q2 25
$7.9M
$14.5M
Q1 25
$8.0M
$14.0M
Q4 24
$8.0M
$18.0M
Q3 24
$8.1M
$21.7M
Q2 24
$8.0M
$20.5M
Net Profit
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
$-3.8M
$-31.8M
Q3 25
$749.4K
$-19.2M
Q2 25
$355.8K
$-49.1M
Q1 25
$282.9K
$-16.8M
Q4 24
$-1.9M
$-39.9M
Q3 24
$1.1M
$-18.7M
Q2 24
$655.8K
$-22.3M
Gross Margin
CCEL
CCEL
NVTS
NVTS
Q1 26
98.6%
Q4 25
77.9%
38.1%
Q3 25
77.0%
37.9%
Q2 25
76.6%
16.1%
Q1 25
75.1%
37.9%
Q4 24
78.4%
12.4%
Q3 24
73.6%
39.7%
Q2 24
74.8%
39.0%
Operating Margin
CCEL
CCEL
NVTS
NVTS
Q1 26
-260.6%
Q4 25
-50.6%
-567.3%
Q3 25
24.3%
-192.0%
Q2 25
18.8%
-149.4%
Q1 25
13.3%
-180.5%
Q4 24
-1.5%
-216.9%
Q3 24
17.2%
-133.6%
Q2 24
17.3%
-152.1%
Net Margin
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
-48.7%
-436.1%
Q3 25
9.6%
-190.2%
Q2 25
4.5%
-338.7%
Q1 25
3.5%
-120.1%
Q4 24
-23.2%
-221.7%
Q3 24
13.0%
-86.4%
Q2 24
8.2%
-109.1%
EPS (diluted)
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
$-0.46
$-0.14
Q3 25
$0.09
$-0.09
Q2 25
$0.04
$-0.25
Q1 25
$0.03
$-0.09
Q4 24
$-0.23
$-0.22
Q3 24
$0.13
$-0.10
Q2 24
$0.08
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
NVTS
NVTS
Cash + ST InvestmentsLiquidity on hand
$3.3M
$221.0M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$420.0M
Total Assets
$61.7M
$481.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
NVTS
NVTS
Q1 26
$221.0M
Q4 25
$3.3M
$236.9M
Q3 25
$3.2M
$150.6M
Q2 25
$4.4M
$161.2M
Q1 25
$3.5M
$75.1M
Q4 24
$3.5M
$86.7M
Q3 24
$2.1M
$98.3M
Q2 24
$1.5M
$111.7M
Total Debt
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Stockholders' Equity
CCEL
CCEL
NVTS
NVTS
Q1 26
$420.0M
Q4 25
$-18.6M
$443.7M
Q3 25
$-14.8M
$371.0M
Q2 25
$-15.6M
$388.9M
Q1 25
$-14.7M
$341.8M
Q4 24
$-13.2M
$348.0M
Q3 24
$-9.6M
$380.8M
Q2 24
$-10.7M
$388.1M
Total Assets
CCEL
CCEL
NVTS
NVTS
Q1 26
$481.4M
Q4 25
$61.7M
$500.5M
Q3 25
$63.2M
$430.2M
Q2 25
$64.4M
$449.4M
Q1 25
$64.4M
$370.8M
Q4 24
$64.7M
$390.0M
Q3 24
$62.9M
$419.4M
Q2 24
$62.6M
$439.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
NVTS
NVTS
Operating Cash FlowLast quarter
$1.3M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
$1.3M
$-8.1M
Q3 25
$2.5M
$-10.0M
Q2 25
$707.0K
$-11.2M
Q1 25
$954.1K
$-13.5M
Q4 24
$2.2M
$-10.2M
Q3 24
$2.4M
$-13.7M
Q2 24
$1.8M
$-15.1M
Free Cash Flow
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
$1.2M
$-8.2M
Q3 25
$2.5M
$-10.7M
Q2 25
$644.6K
$-11.9M
Q1 25
$892.0K
$-13.6M
Q4 24
$2.1M
$-10.8M
Q3 24
$2.3M
$-14.3M
Q2 24
$21.5K
$-17.9M
FCF Margin
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
15.5%
-111.8%
Q3 25
31.9%
-106.1%
Q2 25
8.1%
-82.2%
Q1 25
11.2%
-96.8%
Q4 24
26.8%
-59.8%
Q3 24
27.9%
-65.9%
Q2 24
0.3%
-87.3%
Capex Intensity
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
0.9%
0.7%
Q3 25
0.5%
7.0%
Q2 25
0.8%
4.7%
Q1 25
0.8%
0.3%
Q4 24
0.1%
3.1%
Q3 24
2.3%
2.6%
Q2 24
21.8%
13.4%
Cash Conversion
CCEL
CCEL
NVTS
NVTS
Q1 26
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons